leadf
logo-loader
viewEmpower Clinics Inc.

Empower Clinics launches psilocybin research and psychedelic treatment subsidiary

The company believes psilocybin could be an effective treatment for mental health issues like depression, addiction and PTSD

Mushrooms
Empower operates wellness clinics throughout the US and produces CBD products under the brand name Solievo

Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF), the CBD product producer and wellness clinic operator, has created a subsidiary company focused on psilocybin research and psychedelics therapy in the treatment of mental health issues. 

To get there, the company is leveraging its existing clinic network, which boasts some 165,000 patients and a robust team of physicians, along with its franchise CBD brand and telemedicine capabilities.

“Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the coronavirus pandemic.” Empower CEO Steven McAuley said in a statement.

“Clinical trials continue to show that psilocybin therapies may provide tremendous help with these conditions that we see every day in our clinics. As a company, we must endeavour to utilize our assets and capabilities to positively impact patients’ lives.”

READ: Empower Clinics closes private placement and launches immune system telemedicine services

The company pointed to estimates from Future Market Insights that the mental health crisis could cost the world $16 trillion by 2030, and the global behavioral health (non-pharmacological) market will be around $156 billion by 2028.

In the US, the Food and Drug Administration has given a breakthrough therapy designation to a psilocybin therapy, the company noted, thanks to preliminary clinical evidence indicating that psilocybin may demonstrate substantial improvement over other available therapies for treatment-resistant depression.

Empower, based in Vancouver, operates wellness clinics throughout the US that are geared towards helping patients improve and protect their health through physician-recommended treatment options such as CBD.

The firm also produces a proprietary line of CBD-based products distributed throughout the US.

The company’s CBD is manufactured under the brand name Solievo, and the Sun Valley Health Clinics operate at nine locations in the US. It is the operator of an extraction facility in Oregon.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: Empower Clinics Inc.

Price: 0.055 CAD

CSE:CBDT
Market: CSE
Market Cap: $9.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Empower Clinics Inc. named herein, including the promotion by the Company of Empower Clinics Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Quadrise Fuels International completes industrial pilot for alternative fuel...

Quadrise Fuels International PLC's (LON:QFI) Mike Kirk and Jason Miles talk to Proactive's London's Katie Pilbeam about the completion of their alternative fuel trial, MSAR, at an international chemical group customer’s plant in Morocco. Kirk explains the potential and opportunities for their...

17 hours, 57 minutes ago

2 min read